by Jordana Choucair | Jan 12, 2022 | Life Sciences
The federal government ordered another 600,000 doses of GlaxoSmithKline PLC and Vir Biotechnology Inc.’s monoclonal antibody treatment for COVID-19. The drugmakers plan to deliver the treatment, which is the only one thought to work against the Omicron variant,...
by Jordana Choucair | Jan 11, 2022 | Life Sciences
In separate interviews Monday, the CEOs of Pfizer and Moderna told CNBC that vaccines that protect against the Omicron variant should be available within months. According to Pfizer CEO Albert Bourla, its vaccine that will protect against Omicron and achieve better...
by Jordana Choucair | Jan 11, 2022 | Life Sciences
HHS Secretary Xavier Becerra ordered Medicare to “reassess” a proposed premium increase after Biogen’s Aduhelm fell in price. “Today I’m instructing the Centers for Medicare and Medicaid Services (CMS) to reassess the recommendation for the 2022 Medicare Part B...
by Jordana Choucair | Jan 10, 2022 | Life Sciences
Pfizer Inc. will pay up to $1.35 billion to partner with gene-editing specialist Beam Therapeutics Inc. The four-year deal will allow Pfizer to develop three drugs for rare genetic diseases of the liver, muscle, and central nervous system using base editing, a...
by Jordana Choucair | Jan 10, 2022 | Life Sciences
Moderna donated 2.7 million COVID-19 vaccine doses to Mexico as cases surge in the country. The donations arrived on Saturday at an airport in Toluca after the country this week surpassed more than 300,000 total confirmed coronavirus deaths. The government said the...
by Jordana Choucair | Jan 10, 2022 | Life Sciences
The FDA on Friday authorized adults 18 and older who are vaccinated with Moderna to get a booster shot five months after their second dose, shortening the waiting period by a month. Days earlier, the agency shortened the booster shot waiting period for everyone 12 and...
Recent Comments